Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RT-310
- Development stage
- Unknown
- Lead developer
- Resurge Therapeutics
- Modality
- Small Molecules
- Administration
- Intraprostatic
01
Overview
RT-310 is an investigational intraprostatic drug-eluting implant developed by Resurge Therapeutics for the treatment of Benign Prostatic Hyperplasia (BPH) and associated Lower Urinary Tract Symptoms (LUTS). The product consists of a bioabsorbable PLGA polymer matrix containing paclitaxel, a microtubule-stabilizing agent with cytostatic and cytotoxic properties. RT-310 is designed for a one-time, minimally invasive administration to provide sustained, localized drug release directly to the prostate gland. This targeted delivery aims to inhibit cell proliferation and reduce prostate volume while minimizing the systemic exposure and side effects typically associated with paclitaxel. It is currently being evaluated in Phase 1/2 clinical trials.
- Brand names
- RT-310RT310RT 310
- Other names
- RT-310 implantRT310 implantRT 310 implantpaclitaxel intraprostatic implant
02
Targets
TUBB (Tubulin (alpha and beta subunits))
Beyond the preview
Go deeper on RT-310.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RT-310.